Switch to:

Arrowhead Pharmaceuticals Financial Strength

: 8 (As of Jun. 2020)
View and export this data going back to 1997. Start your Free Trial

Arrowhead Pharmaceuticals has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

Arrowhead Pharmaceuticals Inc shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

GuruFocus does not calculate Arrowhead Pharmaceuticals's interest coverage with the available data. Arrowhead Pharmaceuticals's debt to revenue ratio for the quarter that ended in Jun. 2020 was 0.78. As of today, Arrowhead Pharmaceuticals's Altman Z-Score is 59.48.


Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arrowhead Pharmaceuticals Financial Strength Distribution

* The bar in red indicates where Arrowhead Pharmaceuticals's Financial Strength falls into.



Arrowhead Pharmaceuticals Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Arrowhead Pharmaceuticals's Interest Expense for the months ended in Jun. 2020 was $0.0 Mil. Its Operating Income for the months ended in Jun. 2020 was $-15.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $20.4 Mil.

Arrowhead Pharmaceuticals's Interest Coverage for the quarter that ended in Jun. 2020 is

GuruFocus does not calculate Arrowhead Pharmaceuticals's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies interest coverage is at least 5. Arrowhead Pharmaceuticals Inc has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Arrowhead Pharmaceuticals's Debt to Revenue Ratio for the quarter that ended in Jun. 2020 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2020 ) / Revenue (Q: Jun. 2020 )
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.012 + 20.36) / 27.376
=0.78

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Arrowhead Pharmaceuticals has a Z-score of 59.48, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 59.48 is strong.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals  (NAS:ARWR) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Arrowhead Pharmaceuticals has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.


Arrowhead Pharmaceuticals Financial Strength Related Terms


Arrowhead Pharmaceuticals Financial Strength Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)